Ligand profile
NU4
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_00203 — putative 8-amino-7-oxononanoate synthase/2-amino-3-ketobutyrate coenzyme A ligase
Identifiers
Database identifiers and provenance.
- Ligand ID
NU4- PDB
5qqw- UniProt (similar protein)
P22557- Target protein
- KP13_00203
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 55.1
- −1 ≤ LogP ≤ 5 2.24
- MW ≤ 500 Da 202.2
- LogP ≤ 5 2.24
- H-bond donors ≤ 5 1
- H-bond acceptors ≤ 10 3
- Rotatable bonds ≤ 10 2
- TPSA ≤ 140 Ų 55.1
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
Cc1c(cco1)C(=O)Nc2ccncc2Cc1c(cco1)C(=O)Nc2ccncc2
InChI=1S/C11H10N2O2/c1-8-10(4-7-15-8)11(14)13-9-2-5-12-6-3-9/h2-7H,1H3,(H,12,13,14)InChI=1S/C11H10N2O2/c1-8-10(4-7-15-8)11(14)13-9-2-5-12-6-3-9/h2-7H,1H3,(H,12,13,14)
YQBDLYFUZJNLDH-UHFFFAOYSA-NYQBDLYFUZJNLDH-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00155
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand NU4 →
- PDB RCSB structure 5qqw →
- UniProt UniProt P22557 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “NU4”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_00203.
PDB 32
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 1
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).